Skip to search boxSkip to navigationSkip to main content

Ischemic stroke, part 2: Optimal treatment and prevention

*Corresponding author for this work
  • University of New Mexico
Scholary Output:
Contribution to journal
Short survey
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The goal of medical treatment during acute cerebral infarction is to enhance thrombolysis and inhibit the chemical alterations associated with cell death. Treatment includes avoidance of blood pressure reduction, blood glucose control, possible anticoagulation with IV heparin, and sometimes reduction of cerebral edema. Optimal treatment thereafter depends on the result of patient evaluation. Uncontrolled vascular risk factors (eg, hypertension, smoking, and diabetes) should be treated. Aspirin and ticlopidine reduce the risk of recurrent ischemic stroke. In patients with nonrheumatic atrial fibrillation, anticoagulation with warfarin reduces the risk of embolic events. Carotid endarterectomy is superior to medical management alone in reducing the risk of stroke in patients with >70% symptomatic extracranial carotid stenosis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Short survey
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 37-54 (18 pages)

Journal (Volume, Issue Number)

Geriatrics (Volume 48, Issue 3)

Publication milestones

  • Published - 1993

Publication status

Published - 1993

ISSN

0016-867X

Publication IDs

  • Scopus: 0027232831
  • PubMed: 8449420

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX

Citation count
4
Captures
27